Corrigendum: Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014
Elena Tsvetkova(St Petersburg University), Timothy R. Asmis(Ottawa Hospital), Michael P. Thirlwell(McGill University Health Centre), Stephanie Yasmin Brule(Ottawa Hospital), Conrad Falkson(Sunnybrook Health Science Centre), Shelly Sud(Ottawa Hospital), Mustapha Tehfé(Centre Hospitalier de l’Université de Montréal), Nathalie Aucoin(McGill University Health Centre), C. Cripps(Canadian Partnership Against Cancer), Ronald L. Burkes(Mount Sinai Hospital), Celia Marginean(Sunnybrook Health Science Centre), Bruce Colwell, M. Dorreen(Saint John Regional Hospital), Neil R. Michaud(Epizyme (United States)), Benoît Samson(Hôpital Charles-Le Moyne), F Halwani(Queen's University), Jean A. Maroun(American Society of Clinical Oncology), Rakesh Goel(Ottawa Hospital), Michael M. Vickers(Ottawa Hospital), J. Biagi(Queen's University)
Cited by 0
Related Papers
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
|Annals of Oncology|2014|603
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials
|European Journal of Cancer|1999|414